Explore the first European framework contracts for pandemic influenza

Sequirus, a global leader in influenza prevention, has made it known that pandemic influenza vaccines are part of the response to a pandemic emergency.

Signing influenza pandemic contracts with the European Commission and 15 European Union Member States, Sequencing is the first influenza vaccine manufacturer to sign these contracts under the EU joint procurement framework.

Influenza and pandemics

A pandemic occurs when an influenza virus that was not previously circulating among humans and to which most people do not have immunity emerges and transmits among humans. As the majority of the population has no immunity to these viruses, an outbreak can result in significant morbidity and mortality.¹

The European Center for Disease Prevention and Control, which has a high incidence of infection in the European Union, with many millions of cases and deaths.²

The commitment of Seqirus

The WHO's Global Influenza Strategy for 2019 – 2030 states that a severe pandemic can result in social and economic effects, including a loss of national economic productivity and severe economic loss.³

HIV / AIDS prevention, prevention, prevention, prevention, prevention, prevention, prevention, prevention, prevention, prevention.

One of the world's greatest public health challenges

"According to the WHO, influenza remains one of the world's greatest public health challenges and is not one of pandemic, but when. We are committed to influencing vaccines during a pandemic emergency, "said Gordon Naylor, President, Seqirus.

With leading influenza vaccine technologies and expertise dating back to the Spanish flu pandemic of 1918, Seqirus is a trusted partner to governments around the world.

The development of the EU is being driven by the H1N1 influenza pandemic in 2009, which highlighted the lack of consistent access to pandemic vaccines between EU countries.

References

1. WHO. (2014). Influenza virus infections in humans. Retrieved from: https://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans_feb14.pdf?ua=1.Accessed March 2019.
2. European Center for Disease Prevention and Control. (2019) Questions and answers on influenza pandemics. Retrieved from: https://ecdc.europa.eu/en/pandemic-influenza/facts/questions-and-answers. Accessed March 2019.
3. WHO. (2019). Global influenza strategy 2019-2030. Retrieved from: https://apps.who.int/iris/bitstream/handle/10665/311184/9789241515320-eng.pdf?sequence=1&isAllowed=y. Accessed March 2019.